By Nick O'Brien
As 2018 winds down and the holidays approach, the spirit of giving has begun. Many are reflecting on the year and setting new goals for 2019 – including clinical researchers. As the industry reflects on the past twelve months, we can see rapid change and strides to overcome long-standing research hurdles. Still, despite this progress, … Read More →
By Nick O'Brien
The medical device and diagnostics industries may not represent the face, so to speak, of clinical research. That distinction may belong to pharma, with its blockbuster drugs and lion’s share of the total number of clinical trials registered worldwide. But it would be a folly to underestimate the surge of energy, coming from both industry … Read More →
By Nick O'Brien
Laurie Hook is a clinical and regulatory research consultant and a seasoned expert in electronic data capture implementation. She specializes in medical device clinical research in startup environments, and has worked closely with Medrio customers conducting innovative clinical trials in this space and elsewhere. We recently got the chance to chat with Laurie about the … Read More →
By Nick O'Brien
China is experiencing a surge in activity in pharma clinical trials, becoming an increasingly central part of the pharmaceutical industry. Now the world’s second-largest national pharmaceutical market, China is also pharma’s fastest growing market, with even more significant expansion predicted by 2022. With greater outsourcing to APAC, and modern technology like EDC and eSource allowing … Read More →
By Nick O'Brien
It’s always exciting for us when a Medrio customer wins regulatory approval for a new product. We’d like to congratulate KindredBio, an organization doing fascinating research in the Animal Health sector, on their recent approval of Mirataz. KindredBio used Medrio EDC in clinical trials for Mirataz, and we’re proud to have partnered with them in … Read More →
By Nick O'Brien
The often daunting challenges of pharmaceutical development are no secret: throughout the industry, stakeholders experience hefty price tags, lengthy timelines, and difficulties with patient recruitment and retention. According to Pharmaceutical Research and Manufacturers, it takes an average of ten years and $2.6 billion to develop a new drug – and there is typically just a … Read More →
By Nick O'Brien
After months of development, extensive beta testing, and lots of user feedback, we’ve reached a milestone moment here at Medrio: Medrio eConsent, our tablet application enhancing electronic informed consent in clinical trials, is now live! Last week, the platform officially became available on Google Play. Getting to this moment was a collaborative effort, with Medrio … Read More →
By Nick O'Brien
Clinical research is undergoing a period of rapid transformation. New technology that focuses on greater speed and efficiency is shaking up all aspects of the research process, from Phase 1 clinical trials to post-market surveillance. The growing use of artificial intelligence, eClinical tools, and mHealth is helping researchers to more quickly overcome challenges with patient … Read More →
By Nick O'Brien
Today’s blog post comes to us from Nathan Waller, Medrio’s managing Director of EMEA and a former Director of Business Development at a global CRO. For CROs, clinical research can at times feel like walking a tightrope. If you can keep your balance, success is waiting for you on the other side of the chasm, … Read More →
By Nick O'Brien
Last month, we launched a social media campaign to raise money for cancer research. We put out a call on our social channels, as well as here on the Medrio blog, for photos of our favorite cat, Dr. GoodData, pledging to donate a dollar to the UCSF Helen Diller Family Comprehensive Cancer Center for each … Read More →